Aghazadeh Behzad
SEC Form 4 insider trading activity
Aghazadeh Behzad has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jul 29, 2026.
On the most recent filing, Aghazadeh Behzad is listed as Director, 10% Owner at Scribe Therapeutics, Inc. Inside the rolling window, Aghazadeh Behzad reported 2 open-market purchases totaling $36.3M in SCTX and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,383,333 SCTX shares on Jul 24, 2026, worth $36.1M.
Companies traded
Other insiders at SCTX
Insider Buying
$36.3M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Aghazadeh Behzad made?
Aghazadeh Behzad has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2026.
Which companies does Aghazadeh Behzad trade?
Aghazadeh Behzad has filed SEC Form 4 disclosures for 1 company, including SCTX.
When was Aghazadeh Behzad's most recent SEC Form 4 filing?
Aghazadeh Behzad's most recent SEC Form 4 filing on Tracefour is dated Jul 29, 2026.
What is Aghazadeh Behzad's total buy and sell value in the current window?
Inside the rolling retention window, Aghazadeh Behzad bought $36.3M and sold $0 based on SEC Form 4 filings.
What was Aghazadeh Behzad's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,383,333 SCTX shares on 2026-07-24, worth $36.1M, per SEC Form 4 filings.